June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Outcomes of diagnostic and therapeutic vitrectomy in uveitis
Author Affiliations & Notes
  • Mariana Ingolotti
    Hospital Universitario Austral, Pilar, Argentina
  • Maria Soledad Ormaechea
    Hospital Universitario Austral, Pilar, Argentina
  • Cristobal A Couto
    Uveítis, Hospital de Clínicas José de San Martin, Buenos Aires, Argentina
  • Mario Joaquin Saravia
    Hospital Universitario Austral, Pilar, Argentina
  • Bernardo Ariel Schlaen
    Hospital Universitario Austral, Pilar, Argentina
  • Footnotes
    Commercial Relationships   Mariana Ingolotti, None; Maria Ormaechea, None; Cristobal Couto, None; Mario Saravia, None; Bernardo Schlaen, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2814. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mariana Ingolotti, Maria Soledad Ormaechea, Cristobal A Couto, Mario Joaquin Saravia, Bernardo Ariel Schlaen; Outcomes of diagnostic and therapeutic vitrectomy in uveitis. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2814.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : To assess the outcomes of diagnostic and therapeutic vitrectomy in uveitis

Methods : This is a retrospective study. Clinical records of patients who underwent vitrectomy for diagnostic or therapeutic reasons from the department of uveitis of Hospital Universitario Austral were reviewed. Collected data included, age, gender, vitrectomy indication, diagnosis, best corrected visual acuity (BCVA) before and 1 month after the procedure. Sensitivity and specificity was calculated. Chi square to compare proportions and t student test for paired media were used as appropriate.

Results : Thirty three patients (19 male, 14 female) with complete data were included in this study. Average age was 46.82 ± 19.51 years. Vitrectomy was performed for diagnostic reasons in 13 cases, while the procedure was performed for therapeutic reasons in 27 cases. Both reasons led to indicate the procedure in 7 cases. Diagnostic vitrectomy (cytology and bacterial/fungal culture) had a sensitivity of 83% and a specificity of 100%. Therapeutic vitrectomy was performed for the treatment of epiretinal membranes in 6 cases (22.22%), rhegmatogenous retinal detachment in 5 cases (18.52%), persistent vitreous opacities in 5 cases (18.52%), chronic postoperative endophthalmitis in 4 cases (14.81%), tractional retinal detachment in 2 cases (7.41%), and 1 case each of fungal endogenous endophthalmitis, posterior subtenon perforation, vitreo macular traction, and vitreous hemorrhage. Only 19 cases out of 27 had BCVA recorded before and after the procedure. BCVA before the procedure was 20/200 or less in 14 cases (73.68 %), while 1 month after the procedure was 20/200 or less in 10 cases (52.63%). The difference was not statistically significant (chi square = 1.81, P>0.05)

Conclusions : Diagnostic vitrectomy has shown to have a high sensitivity and specificity for detecting either a masquerade syndrome or an infection. Although it was not observed a statistically significant difference between BCVA before and after therapeutic vitrectomy, there was a favorable numerical difference on BCVA after vitrectomy.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.